Ultrahuman has launched M2 Live, a new platform for continuous glucose monitoring in the U.S. that does not require a prescription. This is made possible by the integration of Abbott’s over-the-counter Lingo sensor. This allows users to track their blood glucose levels around the clock—sensor subscriptions start at $99 per month. An important note up front: The launch initially applies only to the U.S. market; the platform is not yet available in this form in Germany.
Key Points at a Glance
- Ultrahuman M2 Live integrates Abbott’s over-the-counter CGM sensor, Lingo—no doctor’s visit required
- Prices in the U.S.: single sensor $129, subscription starting at $99 per month
- Successor to the M1 Live platform, which still relied on the prescription-only FreeStyle Libre ($249/month)
- Launching initially only in the U.S.—see below for details regarding Germany
What a non-prescription CGM actually means
A CGM (Continuous Glucose Monitor) is a small sensor with an ultra-thin thread placed under the skin, usually worn on the upper arm. It measures glucose levels around the clock and sends the data to a smartphone. This technology is traditionally associated with diabetes care—where a prescription is required and the devices are correspondingly expensive.
Abbott’s Lingo turns the tables: The biosensor is aimed at health-conscious adults aged 18 and older who do not take insulin, and has been available over the counter in the U.S. since 2024—in some retail stores starting at around $49. Ultrahuman is now tapping into this very sensor. That’s the real trick behind M2 Live: Instead of a medical, prescription-only device (as with its predecessor, M1 Live, which used FreeStyle Libre), the second generation runs on more affordable consumer hardware. This brings the price down from $249 to $99 per month.
More Than Just a Glucose Curve
The sensor itself is relatively simple—the Ultrahuman app does the real work. It displays the live reading in mg/dL, tracks daily trends, and alerts you when you stray from your target range. Things get more interesting when you don’t look at the glucose data in isolation. Ultrahuman combines it with data from its proprietary Smart Ring as well as over 100 blood biomarkers from the Blood Vision service. This is designed to help users understand the “why” behind every spike and every drop.
Jade, Ultrahuman’s AI system, weaves together all this data, linking glucose patterns with sleep, HRV, activity, recovery, and skin temperature. In addition, there are several assessment tools:
- Metabolic Score: a daily score from 0 to 100 that reflects glucose regulation. According to Ultrahuman, it was validated in a multicenter study and published in *Nature *.
- Food Score: a rating from 1 to 10 indicating how much a food affects blood glucose levels.
- Fueling Score: shows how glucose availability affects training, endurance, and recovery.
- OGDb: According to the company, the world’s largest open glucose database, containing anonymized average values for various foods.
Practical: Unlike the more expensive M1 Live, M2 Live works even without the brand’s own device, according to Ultrahuman. However, the platform only delivers its full value when used in combination with the Ring.
The Research Behind It
Ultrahuman points to a body of research that is unusually broad for a consumer product. In addition to the validation of the Metabolic Score published in *Nature*, the company cites a sleep-metabolism study conducted in 2026 with Stanford’s Snyder Lab, which reportedly analyzed 227,860 nights of data from 5,859 adults. According to Ultrahuman, the result is that a consistent sleep schedule is the strongest single predictor of metabolic health. In addition, there is an ongoing GLP-1 study with the Mayo Clinic. This information comes from the manufacturer’s press release and cannot be independently verified by us.
And what does this mean for Germany?
Here’s the key point: M2 Live is explicitly launching only in the U.S., and Abbott’s Lingo is currently a U.S. product. CGM sensors are generally available in Germany—such as the FreeStyle Libre—but they are classified as medical devices here and are primarily intended for diabetes care, often requiring a prescription. An over-the-counter wellness CGM for healthy individuals, as embodied by Lingo in the U.S., falls under a different regulatory framework.
Anyone in Germany looking into self-monitoring is therefore currently more likely to end up with traditional wearables. You can find an overview in our guide to the best fitness trackers. And those who shy away from subscription models like the one from Ultrahuman will find subscription-free alternatives for health tracking with devices like the Amazfit Helio Strap —albeit without glucose monitoring.
Pricing and Availability
Ultrahuman M2 Live is now available in the U.S. via ultrahuman.com; some sources mention a rollout “in the coming weeks.” A single Lingo biosensor costs $129, and the subscription starts at $99 per month. Each sensor can be worn for up to 14 days—though Ultrahuman itself notes that in one study, only about 77 percent of the sensors lasted the full 14 days. Safety information about Lingo is available from Abbott, and all product details are available from Ultrahuman.
Conclusion
Ultrahuman M2 Live makes glucose tracking without a prescription significantly more affordable and accessible—at least in the U.S. The real highlight isn’t the sensor itself, but the software that surrounds it: Combining glucose levels with sleep, activity, and biomarkers provides more context than a simple graph alone. The question remains whether all these data points will ultimately lead to sustainable habits or just become another dashboard. For those in Germany interested in the product, it’s a matter of waiting for now: Given the regulatory landscape, it will likely take some time before an over-the-counter wellness CGM of this kind becomes available here.
Note: This article is for informational purposes only and is not a substitute for medical advice. If you have health questions or suspect a metabolic disorder, a doctor is the right person to consult.